Use of macrophage colony-stimulating factor in the treatment of fungal infections

Clinical Infectious Diseases

Volumn 26, Issue 6, 1998, Pages 1279-1281

  Nemunaitis, John ^a,b  

^a TEXAS ONCOLOGY   (United States)

^b TOPA Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RECOMBINANT COLONY STIMULATING FACTOR 1; SUPEROXIDE;

ADULT; ANTIBIOTIC PROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; HUMAN; INTRAVENOUS CATHETER; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MALE; MONOCYTE; MYCOSIS; NEUTROPENIA; PHAGOCYTOSIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

EID: 0031810759     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516363     Document Type: Review

References (21)

1. Meunier F, Aoun M, Bitar N. Fungal infections in immunocompromised hosts: candidemia in immunocompromised patients. Clin Infect Dis 1992;14:120-5.
2. Goodrich JM, Reed EC, Mon M, et al. Clinical features and analysis of risk factors for invasive Candida infection after marrow transplantation. J Infect Dis 1991;164:731-40.
3. Nemunaitis J. Macrophage function activating cytokines: potential clinical application [review]. Crit Rev Oncol Hematol 1993;14:153-71.
4. Cenci E, Batocci A, Puccetti P, Mocci S, Stanley ER, Bistoni F. Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun 1991;59:868-72.
5. Aukerman SC, Middleton J, Sampson-Johanes A, et al. Biological and preclinical activity of macrophage colony stimulating factor, M-CSF. In: Symann M, Quesenberry P, eds. Hematopoietic growth factors: from the basic to the clinical applications. Cheshire, England: Gardiner-Caldwell Communication, 1991.
6. Yanay N, Yamada M, Motoyoshi K, et al. Effect of human macrophage colony-stimulating factor on granulopoiesis and survival in bone marrow transplanted mice. Jpn J Cancer Res 1990;81:355-62.
7. Broxmeyer HE, Williams DE, Copper S, et al. The influence in vivo of murine colony-stimulating factor-1 on myeloid progenitor cells in mice recovering from sublethal dosage of cyclophosphamide. Blood 1987;68:913-8.
8. Chong KT, Langlois L. Enhancing effect of macrophage colony-stimulating factor (M-CSF) in leukocytes and host defense in normal and immunosuppressed mice. Fed Am Soc Exp Biol J 1988;2:1474.
9. Sullivan R, Fredette JP, Socinski M, et al. Enhancement of Superoxide anion release by granulocytes harvested from patients receiving granulocyte-macrophage colony-stimulating factor. Br J Haematol 1989;71: 475-9.
10. DiPersio JF. Colony stimulating factors: enhancement of effector cell function. Cancer Surveys 1990;9:81-113.
11. Smith PD, Lamerson CL, Banks SM, et al. Granulocyte macrophage colony stimulating factor augments human monocyte fungicidal activity for Candida albicans. J Infect Dis 1990;161:999-1005.
12. Kowanko IC, Ferrante A, Harvey DP, Carman KL. Granulocyte macrophage colony stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation. Clin Exp Immunol 1991;83:225-30.
13. Mayer P, Schutz EE, Lam C, Krice KF, Lieht E. Recombinant murine granulocyte macrophage colony stimulating factor augments neutrophil recovery and enhances resistance to infections in myelo-suppressed mice. J Infect Dis 1991;163:584-90.
14. Nemunaitis J, Meyers JD, Buckner CD, et al. Phase I trial of recombinant human macrophage colony-stimulating factor (rhM-CSF) in patients with invasive fungal infections. Blood 1991;78:907-13.
15. Nemunaitis J. GM-CSF and M-CSF in autologous and allogeneic stem cell transplant. In: Hermann F, Mertelsmann R, eds. Hematopoietic growth factors in clinical applications. Vol. 13. New York: Marcel Decker, 1994:257-83.
16. Nemunaitis J, Dorcy KS, Appelbaum FR, et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993;82:1422-7.
17. Petros WP, Rabinowitz J, Stuart AR, et al. Elevated endogenous serum macrophage colony-stimulating factor in the early stage of fungemia following bone marrow transplantation. Exp Hematol 1994;22: 582-6.
18. Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991;324:17738.
19. Crawford J, Ozer H, Stoller R, et al. Reduction of granulocyte colony stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med 1991;325: 164-70.
20. Bodey GP, Anaissie E, Gutterman J, Raj SV. Role of granulocyte macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Infect Dis 1993;17:705-7.
21. Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TK. Antifungal activity of elutriate human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte macrophage colony-stimulating factor and interferon-γ. J Infect Dis 1994;170:894-9.